EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clonal Haematopoiesis in Type 2 Diabetes: A Review of Mechanistic Links With Inflammation and Cardiovascular Disease

Ludovica Migliozzi, Marella Marassi, Mattia Albiero, Gian Paolo Fadini iD

Diabetes/Metabolism Research and Reviews · 2026

DOI: 10.1002/dmrr.70137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2026. Verfasst von Ludovica Migliozzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Inflammation, Cardiovascular Diseases, Clonal Hematopoiesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal haematopoiesis (CH) has been recognized as an important interface between chronic inflammation, metabolic dysfunction, and the heightened cardiovascular risk observed in type 2 diabetes (T2D). CH arises from somatic mutations that give haematopoietic stem cells a competitive advantage and drive the expansion of pro‐inflammatory myeloid lineages. These mutant cells exhibit amplified IL‐1β production, enhanced NLRP3‐inflammasome activity, and increased chemokine signalling, thereby accelerating atherosclerosis, insulin resistance, and vascular inflammation. At the same time, metabolic disturbances characteristic of T2D promote clonal expansion by weakening normal stem cell fitness and modifying epigenetic regulation. This creates a self‐reinforcing loop in which inflammation and metabolic stress sustain CH growth, while CH‐derived myeloid cells worsen systemic and tissue‐level inflammation. Such interactions may contribute not only to excess coronary disease and heart failure but also to microvascular complications through heightened myelopoiesis, neutrophil activation, and dysfunctional stem‐cell mobilisation. This review integrates epidemiological, mechanistic, and experimental findings to present a unified model in which CH and diabetic metabolic stress act synergistically. We explore the shared pathways (niche remodelling, inflammatory memory, and metabolic rewiring) that underpin this bidirectional relationship and discusses how CH may differentially shape cardiometabolic outcomes. Future perspectives in this field are also discussed, including refining CH detection, integrating clone characteristics into risk stratification, and developing targeted therapies that disrupt the metabolic and inflammatory circuits supporting clonal expansion. Anti‐inflammatory strategies and metabolic modulators may ultimately provide personalised approaches to reduce CH‐associated cardiovascular risk in T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2InflammationCardiovascular DiseasesClonal HematopoiesisHematopoiesisHumansAnimals

Stichwörter der Autor:innen

cardiovascular diseaseclonal haematopoiesisdiabetesinflammationmetabolism

Autor:innen und Institutionen

  • Department of Medicine, University of Padova, Padova, Italy.
  • Veneto Institute of Molecular Medicine, Padova, Italy.

ORCID-Profile: Gian Paolo Fadini

Förderung

  • Ministero dell'Università e della Ricerca

Zitieren

APA

Migliozzi, L., Marassi, M., Albiero, M., & Fadini, G. P. (2026). Clonal Haematopoiesis in Type 2 Diabetes: A Review of Mechanistic Links With Inflammation and Cardiovascular Disease. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70137

Vancouver

Migliozzi L, Marassi M, Albiero M, Fadini GP. Clonal Haematopoiesis in Type 2 Diabetes: A Review of Mechanistic Links With Inflammation and Cardiovascular Disease. Diabetes/Metabolism Research and Reviews. 2026. doi:10.1002/dmrr.70137

BibTeX
@article{Migliozzi2026,
  author = {Migliozzi, Ludovica and Marassi, Marella and Albiero, Mattia and Fadini, Gian Paolo},
  title = {Clonal Haematopoiesis in Type 2 Diabetes: A Review of Mechanistic Links With Inflammation and Cardiovascular Disease},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  doi = {10.1002/dmrr.70137}
}
Kostenlos starten →